Christine Pae KING 5

Harborview offers another new medication for early-stage Alzheimer’s patients: HealthLink

Seattle Christine Pae KING 5 - May 16, 2025

The FDA-approved monoclonal antibody infusion known as donanemab, is showing promise to reduce cognitive decline among early-onset patients. SEATTLE — An estimated 7.2 million Americans age 65 and older are living with...